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Preoperative Nomograms for Predicting Extracapsular Extension 
in Korean Men with Localized Prostate Cancer: A Multi-
institutional Clinicopathologic Study
We developed a nomogram to predict the probability of extracapsular extension (ECE) 
in localized prostate cancer and to determine when the neurovascular bundle (NVB) 
may be spared. Total 1,471 Korean men who underwent radical prostatectomy for 
prostate cancer between 1995 and 2008 were included. We drew nonrandom samples 
of 1,031 for nomogram development, leaving 440 samples for nomogram validation. 
With multivariate logistic regression analyses, we made a nomogram to predicts the 
ECE probability at radical prostatectomy. Receiver operating characteristic (ROC) 
analyses were also performed to assess the predictive value of each variable alone and 
in combination. The internal validation was performed from 200 bootstrap re-samples 
and the external validation was also performed from the another cohort. Overall, 314 
patients (30.5%) had ECE. Age, Prostate specific antigen (PSA), biopsy Gleason score, 
positive core ratio, and maximum percentage of biopsy tumor were independent 
predictors of the presence of ECE (all P values <0.05). The nomogram predicted ECE 
with good discrimination (an area under the ROC curve of 0.777). Our nomogram 
allows for the preoperative identification of patients with an ECE and may prove useful 
in selecting patients to receive nerve sparing radical prostatectomy.
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INTRODUCTION
While classic radical prostatectomy results in impotence and 
decreased quality of life, nerve sparing radical prostatectomy, 
which was introduced in 1983, is a milestone for improving treat-
ment of clinically localized prostate cancer and maintaining 
adequate cancer control (1). However, methods to select the 
patients for nerve sparing radical prostatectomy are still contro-
versial. To date, several selection criteria for nerve sparing radi-
cal prostatectomy have been investigated, including digital rec-
tal examination, biopsy Gleason score, assessing surgical mar-
gins in the region of the neurovascular bundle (NVB) by intra-
operative frozen sections or palpation (2, 3). These criteria are 
subjective and difficult to apply generally due to interclinician 
variability. Most widely used method of the selection is predict-
ing extracapsular extension (ECE), because knowledge of the 
presence of ECE before treatment helps patients and physicians 
make better decisions (4). Therefore, much effort has been paid 
Chung JS, et al. • Nomogram for Predicting Extracapsular Extension
1444  http://jkms.org DOI: 10.3346/jkms.2010.25.10.1443
to the accurate preoperative prediction of the presence or the 
location of ECE. As results of efforts, pretreatment nomograms 
have been constructed on the basis of clinical stage, prostate 
specific antigen (PSA) level, and biopsy Gleason score. Nomo-
grams are simple mathematical formulas or algorithms opti-
mized for predictive accuracy. Such statistical models almost 
always perform better than any individual predictive factor and 
informed clinical judgment (5). Currently, several studies have 
tried to determine selection criteria for nerve-sparing radical 
prostatectomy based on biopsy-derived variables as well as the 
aforementioned factors (4, 6, 7).
 Meanwhile, there are huge differences in incidence and ag-
gressiveness of prostate cancer between Asian and Western coun-
tries (8-12). When compared with age-matched men in West-
ern countries, Asian men have lower normal ranges of serum 
PSA and smaller prostate volumes (13-15). Moreover, almost all 
of the currently available data about the selection of patients for 
nerve sparing radical prostatectomy, especially about predicting 
the presence of ECE, were obtained from studies on Western 
populations. As a consequence, nomograms based on Asian 
data need to be established. Therefore, we developed a model 
predicting the probability of ECE in a multi-institutional cohort 
of Korean men by incorporating a detailed, quantitative assess-
ment of biopsy results into a nomogram.
MATERIALS AND METHODS
Patient population
Nine hospitals of Korea participated in this retrospective multi-
center study. Between January 1995 and December 2008, 1,582 
consecutive patients who underwent radical retropubic prosta-
tectomy for clinically localized prostate cancer without neoad-
juvant therapy were evaluated. To optimize ECE data analysis, 
we excluded 111 patients who underwent bilateral nerve spar-
ing surgery or unilateral nerve sparing including missing values 
since ECE status could not be determined precisely. We anal-
ysed nonrandom samples of 1,031 for nomogram development 
(e.g., according to center), leaving 440 for nomogram validation. 
Patient age, biopsy Gleason score, clinical stage, PSA, PSA den-
sity (PSAD), number of positive biopsy cores and maximum per-
centage of tumor in any core were analyzed preoperatively in 
each case. Prostate volume was measured by Transrectal ultra-
sound (TRUS) using the formula for elliptical volume (π/6*height* 
width*length). PSAD was evaluated as PSA (ng/mL) devided by 
TRUS-estimat ed prostate volume (mL). 
Pathological evaluation
All histological grading of biopsies and prostatectomy specimens 
were pathologically re-analyzed by nine uropathologists who are 
members of the Korean Genitourinary Pathology Study Group. 
In all cases the diagnosis was made by systemic biopsy (6 cores 
or more than 10 cores). The positive core ratio was calculated 
by dividing the number of positive cores by the number of cores 
taken at TRUS biopsy. The maximum percentage of tumor in 
any core was defined as the greatest tumor percent among the 
positive cores of biopsy. Each prostate was sectioned at 4-mm 
intervals in a transverse plane perpendicular to the posterior 
surface. Extracapsular extension was defined as tumor in con-
tact with periprostatic soft tissue.
Statistical analyses
Continuous variables were compared using the Mann-Whitney 
test, whereas categorical variables were compared with chi-
square test. The effect of preoperative variables on predicting 
overall likelihood of extracapsular extension was analyzed with 
multivariate logistic regression models (MLRM). The increment 
in predictive accuracy was determined for each variable and 
was quantified by receiver operating characteristic (ROC) anal-
ysis. Subsequently, MLRM coefficients were used to generate a 
nomogram predicting the probability of ECE at radical prosta-
tectomy. Calibration was carried out for the constructed nomo-
gram and internal validation was analyzed from 200 additional 
bootstrap samples to decrease the overfit bias. External valida-
tion was also performed in another cohort. All analyses were 
performed using SAS version 9.1 statistical software (SAS Insti-
tute, Cary, NC, USA) and R version 2.8.1 (The R Foundation for 
Statistical Computing, Vienna, Austria). 
RESULTS
Preoperative characteristics of prostate cancer patients included 
in our study are listed in Table 1. Histopathologic evaluation of 
Table 1. Comparison of variables between cases with and without ECE 
Variables
Subpopulation for nomogram 
development (n=1,031)
P Value
Subpopulation 
for external 
validation 
(n=440)ECE No ECE
No. of patients (%) 314 (30.5) 717 (69.5)
Mean age (yr) 65.8±7.4 64.2±9.7 <0.001 65.1±8.1
Mean PSA (ng/mL)   17.1±12.7   9.3±6.9 <0.001   9.8±3.8
BMI (kg/m2) 23.6±2.7 23.7±3.1    0.428 23.6±3.0
Prostate volume (mL)   34.7±15.1   37.5±12.2 <0.001   36.8±15.1
Biopsy Gleason score (%)
   <=6
   7
   <=8
  78 (16.3)
147 (35.7)
  89 (64.0)
402 (83.7)
265 (64.3)
  50 (36.0) 
<0.001 186 
186 
  68 
No. of total biopsy cores obtained (%)
   6 
   >=10
  39 (41.9)
275 (87.6)
  54 (58.1)
663 (92.5)
  37 
403 
Mean No. of positive core 4.5±2.6 2.6±1.8 <0.001   3.4±2.1
Mean positive core ratio 0.49±0.26 0.28±0.22 <0.001   0.31±0.17
Maximum % of tumor  
   in any core (range)
61.2±29.3 31.8±26.1 <0.001   39.1±26.0
Data are presented as number (%) or mean±standard deviation.
PSA, prostate specific antigen; BMI, body mass index; PSAD, PSA density.
Chung JS, et al. • Nomogram for Predicting Extracapsular Extension
http://jkms.org  1445DOI: 10.3346/jkms.2010.25.10.1443
prostatectomy specimens revealed extracapsular extension in 
314 (30.5%) of 1,031 patients (Table 1). Of these 1,031 patients, 93 
(9%) underwent TRUS-guided preoperative sextant biopsy, while 
938 (91%) underwent extended biopsy (>=10 cores) schemes. The 
total number of biopsy cores ranged from 6 to 20. When com-
paring variables with and without ECE, all variables except BMI 
were significantly different as shown in Table 1 (P<0.001). Table 
2 shows the multivariate regression analysis fitted in the devel-
opment cohort. Age, PSA, biopsy Gleason score, positive core 
ratio and maximum percentage of tumor on biopsy were inde-
pendent predictors of the presence of ECE (all P  values <0.05). 
A multivariate logistic regression model (MLRM) and ROC curves 
for predicting ECE were constructed with preoperative variables. 
The predictive performances of MLRM and other individual vari-
ables were demonstrated by area under curve (AUC) (Fig. 1). 
After 200 bootstrap re-samples of the nomogram regression co-
efficients, the combined accuracy of the ECE prediction (AUC 
of MLRM) was 77.7% and exceeded the individual variables 
(Table 3). Fig. 2 shows the regression coefficient-based nomo-
gram, which was devised from the predictor variables. Nomo-
gram is used by first locating the patient position on each pre-
dictor variable scale. Each scale position has a corresponding 
prognostic points (top axis). The points for each variable are 
added and the probability of ECE is estimated from the bottom 
line with total points. The performance characteristics of the 
nomogram are shown in Fig. 3A, where the nomogram predict-
ed probability of ECE is represented on the x-axis and the ob-
served rate of ECE is plotted on the y-axis. Perfect prediction 
would correspond to a slope of 1 (diagonal 45-degree dashed 
line). The dotted line represents the apparent accuracy of this 
nomogram without correction for over fit. The solid line indi-
cates bootstrap corrected nomogram performance. The exter-
nal validation cohort data are represented by dotted line in Fig. 
3B, where the solid line represents the logistic calibration of the 
model. The overall discrimination measurement of the valida-
tion cohort was 0.782.
DISCUSSION
With the increased detection of early stage prostate cancer, nerve 
sparing radical prostatectomy has become a matter of great con-
Table 2. Multivariate logistic regression analysis of preoperative predictors for ECE 
after RRP
Variables OR (95% CI) P value
Age 1.05 (1.01-1.08) <0.001
PSA 1.02 (1.01-1.04) 0.021
Biopsy Gleason score
   <=6 Reference
   7 1.02 (0.95-2.11) 0.080
   >=8 1.65 (1.01-3.09) <0.001
Positive core ratio 3.18 (1.69-6.68) <0.001
Max % of tumor at any biopsy site 1.02 (1.01-1.04) <0.001
PSAD 1.11 (0.53-2.59) 0.071
ECE, extracapsular extension; RRP, radical retropubic prostatectomy; CI, confidence 
interval; PSA, prostate specific antigen; PSAD, PSA density; OR, odds ratio.
Table 3. Predictive accuracy for ECE based on ROC curve using standard information
Variables AUC (95% CI)
Age 0.575 (0.541-0.598)
PSA 0.689 (0.655-0.723)
Biopsy Gleason score sum 0.675 (0.644-0.711)
Positive core ratio 0.708 (0.671-0.739)
Max % of tumor at any biopsy site 0.731 (0.718-0.765)
PSAD 0.707 (0.681-0.750)
MLRM 0.777 (0.762-0.803)
ECE, extracapsular extension; ROC, receiver operating characteristics; AUC, area under 
curve; PSA, prostate specific antigen; PSAD, PSA density; MLRM, multivariate logistic 
regression models.
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Fig. 1. Receiver operating characteristics (ROC) curve of multivariate logistic regression 
model (MLRM) for predicting extracapsular extension (ECE) in prostate cancer.
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Fig. 2. Nomogram for predicting ECE in localized prostate cancer. Find the position of 
each variable on the corresponding axis, draw a line to the ‘points’ axis for the number 
of points, add the points from all the variables together and draw a line from the ‘total 
points’ axis to determine the extracapsular extension probabilities at the bottom. 
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cern. Although the selection criteria for nerve sparing radical 
prostatectomy have not been thoroughly determined at pres-
ent, men with pathologically organ-confined cancer have been 
regarded as the best candidates for nerve sparing radical pros-
tatectomy (7). Extracapsular extension of prostate cancer is close-
ly connected to a potential risk for a positive surgical margin, 
which is important due to its adverse outcome for prostate can-
cer. Consequently, it is essential to know the existence of ECE 
preoperatively to preserve postoperative quality of life and to 
control the cancer. 
 Over the past few years, several studies have investigated the 
possibility of the presence or location of ECE using preoperative 
clinical and pathologic factors (7, 16, 17). Sebo et al. (18) studied 
207 patients and found that the percent positive cores and per-
cent cancer in systematic biopsies were the strongest predictors 
of extension beyond the prostate in a stepwise logistic regression 
analysis. More recently, several models predicting side-specific 
ECE have been also reported. Data from Naya et al. (17) also in-
dicated that the maximum cancer length in positive cores is a 
significant risk factor of side-specific posterolateral ECE, inde-
pendent of biopsy Gleason score. Ohori et al. (16) attempted to 
further improve the accuracy of the internally validated nomo-
grams to predict the side specific probability of ECE based on 
sextant-based biopsy. Tsuzuki et al. (4) also reported a model 
predicting side-specific posterolateral ECE using PSA, finding 
of digital rectal examination, biopsy Gleason score, average per-
cent of prostatic tissue involved with tumor and percent of posi-
tive core. However, in reality, most of the available reports on the 
selection of patients for nerve sparing radical prostatectomy, 
especially about predicting the presence of ECE, were based on 
data from Western populations. It is well known that geographi-
cal and ethnic differences in prostate cancer risk exist. A lower 
incidence of prostate cancer in Asian and Korean men than in 
European men has been reported (19). In addition, age-match-
ed Korean men have lower normal serum PSA ranges, and their 
average total prostate volume is smaller than that of European 
men (13). In addition, prostate cancer screening in Korea is cur-
rently not as widespread as in Western countries, and prostate 
cancer in Korea is generally not detected as early as in Western 
countries. This situation may have contributed to the differenc-
es in cancer biology. Taken together, these differences may limit 
the usefulness of preexisting nomograms and has prompted ef-
forts to develop a new model for a more accurate preoperative 
prediction of ECE which is suitable for Korean men.
 In the current study, we focused only on the probability of 
presence of ECE, irrespective of location, and especially, the re-
gion of the neurovascular bundle (NVB). Our data showed that 
ECE was seen in 30% of all patients. The incidence of ECE in lo-
calized prostate cancer is consistent with that reported in recent 
studies (17, 20). Our nomogram included six variables: age, PSA, 
PSA density, biopsy Gleason score, biopsy positive core ratio and 
maximum percent of tumor in any core. Since the number of 
cores sampled varies among institutions, we chose the fraction 
of positive cores in reporting the number of cores, rather than 
the absolute number of positive cores. All of these predictors are 
relatively easy to collect clinically before surgery. Our nomogram 
seems to be simple and practical with a relatively high area un-
der the ROC curve, thus exhibiting good performance. We quan-
tified the gain in predictability on the basis of an increase in the 
area under the ROC curve. The AUC of our full model nomogram 
incorporating PSA, clinical stage, PSA density, biopsy Gleason 
score, percent positive cores and maximum percent of tumor in 
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Fig. 3. (A) Calibration curves of preoperative nomogram in internal validation cohort. The x-axis is the predicted probability from the nomogram, and the y-axis is the actual 
probability of ECE. The dashed line represents performance of the ideal nomogram (predicted outcome perfectly corresponds with actual outcome). The dotted line represents 
the apparent accuracy of our nomogram without correction for over fit. The solid line represents bootstrap-corrected performance of our nomogram. (B) Calibration plot of 
nomogram in external validation cohort (n=440). Solid line indicates logistic calibration curve and dotted line represent data for validation cohort. 
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any core was 0.777. These findings support our selection of vari-
ables for determining suitable candidates for nerve sparing rad-
ical prostatectomy.
 Our investigation has several distinctive features. First, our 
data regarding ECE were maximized because only non-nerve 
spared patients were evaluated. The ECE status could be evalu-
ated precisely. Second, while most of published data on the pre-
diction of actual ECE of prostate cancers before surgery have 
been based on patient cohorts who underwent prostate biopsy 
with a relatively limited number of cores, as in sextant biopsy, 
we mainly included men who underwent extended biopsy (>=10 
cores). Only 93 (9%) patients underwent sextant biopsy. Third, 
although we did not present the data, our nomogram was ap-
plicable to low risk (biopsy GS <=7) and high risk (biopsy GS >=8) 
group. Fourth, the descriptive cancer statistics presented in this 
study provide representative data that illustrate the characteris-
tics of prostate cancer in Korean men. Moreover, the pathologic 
slides were re-evaluated by 9 uropathologists who had fully dis-
cussed the pathological assessment criteria including biopsy 
Gleason grading to improve interobserver reproducibility in our 
study. We believe that our nomograms will assist physicians in 
counseling Korean men as well as Asian men with prostate can-
cer regarding the probability of the presence of ECE. 
 The potential limitations of this study should be considered. 
The internal validation was calculated by 200 additional boot-
strapping samples to decrease the overfit bias. Although boot-
strapping has been shown to represent the best alternative to 
external validation (21) and external validation was performed 
with subpopulation group, our accuracy results were not vali-
dated in different population and may still be affected by resid-
ual overfit bias. Another limitation is that we could not assess 
the site-specific ECE in the NVB region nor confirm the identi-
fication of the biopsy positive site and ECE site of prostatectomy 
specimens since many of our cases were from outside institu-
tions where this information was not available. Therefore, our 
study provides no information about the location of the ECE. 
However, it had been reported that the majority of ECE occurs 
at the posterolateral border of the prostate. Villers et al. (22) 
showed that capsular penetration of cancerous tissue is often 
present at the neurovascular bundle. Others have indicated that 
the most common location of extracapsular extension in palpa-
ble tumors is posterolateral, near the neurovascular bundle (23-
25). Hence this nomograms derived from our site-nonspecific 
risk of ECE can be helpful in selecting patients suited for nerve 
sparing or non-nerve sparing prostatectomy. In this study, we 
did not use specific cutoff values for the respective variables, 
because the nomograms were not designed to be used with a 
specific cutoff. Despite these limitations, this model may offer 
an effective tool with which to select men who are suitable can-
didates for nerve sparing radical prostatectomy in the era of ex-
tended biopsy schemes.
 In conclusion, we constructed a nomogram to predict the 
probability of extracapsular extension in prostate cancer based 
on the data of age, serum PSA levels, prostate volume and sys-
tematic biopsy results. In an era when less aggressive surgical 
treatments are being encouraged for localized prostate cancer, 
our model represents an important contribution and may assist 
patients and physicians in making surgical decisions.
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